| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 95.160 | 8.127 | 54.171 | 136.683 | 66.983 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | 95.160 | 8.127 | 54.171 | 137.792 | 67.996 | 1.789 | 0 | 0 | 0 |
| Total Expenses - EUR | - | 10.242 | 14.061 | 10.368 | 15.394 | 16.958 | 9.197 | 20 | 20 | 60 |
| Gross Profit/Loss - EUR | - | 84.919 | -5.934 | 43.804 | 122.397 | 51.038 | -7.408 | -20 | -20 | -60 |
| Net Profit/Loss - EUR | - | 83.967 | -6.015 | 43.262 | 121.030 | 50.424 | -7.511 | -20 | -20 | -60 |
| Employees | - | 2 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Cardio Plus Research Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 1.712 | 2.676 | 1.887 | 2.676 | 4.214 | 3.085 | 3.095 | 3.086 | 3.068 |
| Current Assets | - | 84.394 | 2.456 | 36.145 | 118.962 | 50.933 | 1.102 | 1.106 | 1.102 | 1.096 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 1.050 | 240 | 25 | 98 | 1.031 | 1.102 | 1.106 | 1.102 | 1.096 |
| Cash | - | 83.344 | 2.216 | 8.184 | 12.546 | 10.546 | 0 | 0 | 0 | 0 |
| Shareholders Funds | - | 84.012 | -5.963 | 37.409 | 121.080 | 50.474 | -7.462 | -7.506 | -7.503 | -7.522 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 2.094 | 11.406 | 908 | 1.360 | 5.315 | 11.650 | 11.706 | 11.691 | 11.686 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cardio Plus Research Srl